SBIR Phase I: Development of a Burn Care Therapy to Prevent Fibrotic Pathologies — NSF Award to TREYSTA MEDICAL TECHNOLOGIES INC (
The broader impact/commercial potential of this small business innovation research (SBIR) Phase I project lies in its potential to transform outcomes for US burn injury survivors; a population burdened by disfigurement, physical limitation, and long-term psychological impacts. While current treatments focus primarily o
| Award title | SBIR Phase I: Development of a Burn Care Therapy to Prevent Fibrotic Pathologies |
|---|---|
| Award ID | 2528240 |
| Awardee | TREYSTA MEDICAL TECHNOLOGIES INC |
| City | GAINESVILLE |
| State | FL |
| Amount obligated | $304,984 |
| Principal investigator | Marcelo Buzzi |
| Program | SBIR Phase I |
| Start date | 10/01/2025 |
| Abstract | The broader impact/commercial potential of this small business innovation research (SBIR) Phase I project lies in its potential to transform outcomes for US burn injury survivors; a population burdened by disfigurement, physical limitation, and long-term psychological impacts. While current treatments focus primarily on survival, many patients face permanent reductions in quality of life due to scarring and contractures. This project aims to develop a novel burn care system that actively manages |
| Source | NSF Awards |
$799/mo
Try NSFGrants →